HUTCHMED (China) Ltd Files October 2025 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1648257
Sentiment: neutral
Topics: reporting, foreign-private-issuer, pharmaceuticals
TL;DR
HUTCHMED (China) Ltd filed its monthly 6-K report on Oct 14, 2025, confirming its status as a foreign private issuer.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on October 14, 2025. This report is for the month of October 2025 and indicates the company is a foreign private issuer filing under the 1934 Securities Exchange Act. The company is headquartered in Hong Kong and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides routine updates for HUTCHMED (China) Limited, a significant player in the pharmaceutical sector, informing investors about its ongoing compliance and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former company name
- 20251014 (date) — Filing date and period of report
- 001-37710 (other) — SEC file number
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was this specific Form 6-K filed?
This Form 6-K was filed on October 14, 2025.
What is HUTCHMED (China) Limited's primary business sector?
HUTCHMED (China) Limited is classified under Standard Industrial Classification 2834, which is Pharmaceutical Preparations.
What was HUTCHMED (China) Limited's former name?
The company's former name was Hutchison China MediTech Ltd.
Where is HUTCHMED (China) Limited's principal executive office located?
The principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Filing Stats: 184 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2025-10-14 06:08:18
Filing Documents
- hcm-20251014x6k.htm (6-K) — 22KB
- hcm-20251014xex99d1.htm (EX-99.1) — 27KB
- hcm-20251014xex99d2.htm (EX-99.2) — 22KB
- hcm-20251014xex99d1001.gif (GRAPHIC) — 4KB
- hcm-20251014xex99d2001.gif (GRAPHIC) — 4KB
- 0001648257-25-000071.txt ( ) — 84KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of Octo ber 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to FRUSICA-2 registration trial data to be presented at the 2025 ESMO Congress Exhibit 99.2 Announcement relating to appointment of Independent Non-Executive Director and member of board committee 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: October 14, 2025 3